PDF herunterladen
Drug Res (Stuttg) 2024; 74(04): 156-163
DOI: 10.1055/a-2263-1329
Original Article

Therapeutic Potential of Diosgenin in Amelioration of Carbon Tetrachloride-Induced Murine Liver Injury

Mohamad-Hasan Ghosian-Moghaddam
1   Department of Biochemistry, Faculty of Medicine, Shahed University, Tehran, Iran
,
Parvaneh Mohseni-Moghaddam
2   Department of Physiology, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
,
Mehrdad Roghani 
3   Neurophysiology Research Center, Shahed University, Tehran, Iran
› Institutsangaben Funding Information National Institute for Medical Research Development — http://dx.doi.org/10.13039/501100012155; 943783
› Weitere Informationen
Auch verfügbar auf
    Lizenzen und Reprints

Abstract

Diosgenin is a sapogenin with antidiabetic, antioxidant, and anti-inflammatory properties. The current study investigated whether diosgenin could ameliorate carbon tetrachloride (CCL4)-induced liver injury. To cause liver injury, CCL4 was injected intraperitoneally twice a week for 8 weeks. Daily oral administration of diosgenin at doses of 20, 40, and 80 mg/kg was started one day before CCL4 injection and continued for 8 weeks. Finally, serum levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and also albumin were assessed. Catalase and superoxide dismutase (SOD) activities in addition to glutathione (GSH) and malondialdehyde (MDA) levels were also quantified in the liver homogenate and routine histological evaluation was also conducted. Elevated serum levels of liver enzymes and decreased serum level of albumin caused by CCL4 were significantly restored following diosgenin administration at doses of 40 and 80 mg/kg. Long-term administration of CCL4 increased inflammatory and apoptotic factors such as IL-1β, caspase 3, TNF-α, and IL-6 and decreased SOD and catalase activities as well as GSH level in liver homogenates; while MDA level was increased. Treatment with diosgenin increased SOD and catalase activities and GSH levels in the liver of injured animals. In addition, liver MDA, IL-1β, caspase 3, TNF-α, and IL-6 level or activity decreased by diosgenin treatment. Additionally, diosgenin aptly prevented aberrant liver histological changes. According to obtained results, diosgenin can dose-dependently diminish CCl4-induced liver functional deficits and histological changes in a dose-dependent manner, possibly due to its antioxidant and anti-inflammation properties, and its beneficial effect is comparable to known hepatoprotective agent silymarin.

Keywords

liver injury - apoptosis - CCL4 - diosgenin - oxidative stress - inflammation - silymarin


Publikationsverlauf

Eingereicht: 10. Februar 2023

Angenommen: 05. Februar 2024

Artikel online veröffentlicht:
08. März 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Ullah H, Khan A, Baig MW, Ullah N, Ahmed N, Tipu MK, Ali H, Khan S. Poncirin attenuates CCL4-induced liver injury through inhibition of oxidative stress and inflammatory cytokines in mice. BMC complementary medicine and therapies 2020; 20: 1-14
    CrossrefPubMedGoogle Scholar
  • 2 Cichoż-Lach H, Michalak A. Oxidative stress as a crucial factor in liver diseases. World journal of gastroenterology: WJG 2014; 20: 8082
    CrossrefPubMedGoogle Scholar
  • 3 Sumida W, Kaneko K, Ono Y, Tainaka T, Ando H. Different polyunsaturated fatty acid profiles in patients with biliary atresia after successful Kasai operation and liver transplantation. Pediatr Surg Int 2009; 25: 255-259
    CrossrefPubMedGoogle Scholar
  • 4 Al-Seeni MN, El Rabey HA, Zamzami MA, Alnefayee AM. The hepatoprotective activity of olive oil and Nigella sativa oil against CCl 4 induced hepatotoxicity in male rats. BMC Complement Altern Med 2016; 16: 1-14
    CrossrefPubMedGoogle Scholar
  • 5 Minami K, Saito T, Narahara M, Tomita H, Kato H, Sugiyama H, Katoh M, Nakajima M, Yokoi T. Relationship between hepatic gene expression profiles and hepatotoxicity in five typical hepatotoxicant-administered rats. Toxicol Sci 2005; 87: 296-305
    CrossrefPubMedGoogle Scholar
  • 6 Yang C, Gong X, Ai Q, Ge P, Lin L, Zhang L. 5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside alleviated carbon tetrachloride-induced acute hepatitis in mice. Int Immunopharmacol. 2015; 25: 393-399
    CrossrefPubMedGoogle Scholar
  • 7 Moselhy SS, Ali HK. Hepatoprotective effect of cinnamon extracts against carbon tetrachloride induced oxidative stress and liver injury in rats. Biol Res 2009; 42: 93-98
    CrossrefPubMedGoogle Scholar
  • 8 Semwal P, Painuli S, Abu-Izneid T, Rauf A, Sharma A, Daştan SD, Kumar M, Alshehri MM, Taheri Y, Das R. Diosgenin: an updated pharmacological review and therapeutic perspectives. Oxid Med Cell Longev 2022; DOI: 10.1155/2022/1035441.
    CrossrefPubMedGoogle Scholar
  • 9 Sethi G, Shanmugam MK, Warrier S, Merarchi M, Arfuso F, Kumar AP, Bishayee A. Pro-apoptotic and anti-cancer properties of diosgenin: a comprehensive and critical review. Nutrients 2018; 10: 645
    CrossrefPubMedGoogle Scholar
  • 10 Kalailingam P, Kannaian B, Tamilmani E, Kaliaperumal R. Efficacy of natural diosgenin on cardiovascular risk, insulin secretion, and beta cells in streptozotocin (STZ)-induced diabetic rats. Phytomedicine 2014; 21: 1154-1161
    CrossrefPubMedGoogle Scholar
  • 11 Wang H-W, Liu H-J, Cao H, Qiao Z-Y, Xu Y-W. Diosgenin protects rats from myocardial inflammatory injury induced by ischemia-reperfusion. Medical science monitor: international medical journal of experimental and clinical research 2018; 24: 246
    CrossrefPubMedGoogle Scholar
  • 12 Cai B, Zhang Y, Wang Z, Xu D, Jia Y, Guan Y, Liao A, Liu G, Chun C, Li J. Therapeutic potential of diosgenin and its major derivatives against neurological diseases: recent advances. Oxid Med Cell Longev. 2020
    PubMedGoogle Scholar
  • 13 Mohamadi-Zarch S-M, Baluchnejadmojarad T, Nourabadi D, Khanizadeh AM, Roghani M. Protective effect of diosgenin on LPS/D-Gal-induced acute liver failure in C57BL/6 mice. Microb Pathog 2020; 146: 104243
    CrossrefPubMedGoogle Scholar
  • 14 Cheng S, Liang S, Liu Q, Deng Z, Zhang Y, Du J, Zhang Yn, Li S, Cheng B, Ling C. Diosgenin prevents high-fat diet-induced rat non-alcoholic fatty liver disease through the AMPK and LXR signaling pathways. Int J Mol Med 2018; 41: 1089-1095
    PubMedGoogle Scholar
  • 15 Zhong Y, Li Z, Jin R, Yao Y, He S, Lei M, Wang X, Shi C, Gao L, Peng X. Diosgenin Ameliorated Type II Diabetes-Associated Nonalcoholic Fatty Liver Disease through Inhibiting De Novo Lipogenesis and Improving Fatty Acid Oxidation and Mitochondrial Function in Rats. Nutrients 2022; 14: 4994
    CrossrefPubMedGoogle Scholar
  • 16 Yan M, Man S, Liang Y, Ma L, Guo L, Huang L, Gao W. Diosgenin alleviates nonalcoholic steatohepatitis through affecting liver-gut circulation. Pharmacol Res 2023; 187: 106621
    CrossrefPubMedGoogle Scholar
  • 17 Nimbalkar VV, Shelke RP, Kadu UE, Gaikwad PM. Protective effect of diosgenin against carbon tetrachloride and cisplatin induced hepatotoxicity in rats. International Journal of Clinical and Biomedical Research 2018; 4: 50-56
    CrossrefPubMedGoogle Scholar
  • 18 Sangeetha M, Mal NS, Atmaja K, Sali VK, Vasanthi HR. PPAR’s and Diosgenin a chemico biological insight in NIDDM. Chem Biol Interact 2013; 206: 403-410
    CrossrefPubMedGoogle Scholar
  • 19 Chiu H-W, Hua K-F. Hepatoprotective effect of wheat-based solid-state fermented Antrodia cinnamomea in carbon tetrachloride-induced liver injury in rat. PLoS One 2016; 11: e0153087
    CrossrefPubMedGoogle Scholar
  • 20 Thakare VN, Patil RR, Oswal RJ, Dhakane VD, Aswar MK, Patel BM. Therapeutic potential of silymarin in chronic unpredictable mild stress induced depressive-like behavior in mice. Journal of Psychopharmacology 2018; 32: 223-235
    CrossrefPubMedGoogle Scholar
  • 21 Wang L, Huang Q-H, Li Y-X, Huang Y-F, Xie J-H, Xu L-Q, Dou Y-X, Su Z-R, Zeng H-F, Chen J-N. Protective effects of silymarin on triptolide-induced acute hepatotoxicity in rats. Mol Med Report 2018; 17: 789-800
    PubMedGoogle Scholar
  • 22 Nasri S, Roghani M, Baluchnejadmojarad T, Rabani T, Balvardi M. Vascular mechanisms of cyanidin-3-glucoside response in streptozotocin-diabetic rats. Pathophysiology 2011; 18: 273-278
    CrossrefPubMedGoogle Scholar
  • 23 Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem. 1968; 25: 192-205
    CrossrefPubMedGoogle Scholar
  • 24 Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959; 82: 70-77
    CrossrefPubMedGoogle Scholar
  • 25 Claiborne A. Handbook of Methods for Oxygen Radical Research. Catalase activity. CRC Press; Inc Boca Raton, FL: 1985
    Google Scholar
  • 26 Khajevand-Khazaei MR, Mohseni-Moghaddam P, Hosseini M, Gholami L, Baluchnejadmojarad T, Roghani M. Rutin, a quercetin glycoside, alleviates acute endotoxemic kidney injury in C57BL/6 mice via suppression of inflammation and up-regulation of antioxidants and SIRT1. Eur J Pharmacol 2018; 833: 307-313
    CrossrefPubMedGoogle Scholar
  • 27 Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254
    CrossrefPubMedGoogle Scholar
  • 28 Rousta AM, Mirahmadi SM, Shahmohammadi A, Mehrabi Z, Fallah S, Baluchnejadmojarad T, Roghani M. Therapeutic Potential of Isorhamnetin following Acetaminophen-Induced Hepatotoxicity through Targeting NLRP3/NF-κB/Nrf2. Drug Res (Stuttg) 2022; 72: 245-254
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 29 Ali SA, Faddah L, Abdel-Baky A, Bayoumi A. Protective effect of L-carnitine and coenzyme Q10 on CCl4-induced liver injury in rats. Sci Pharm 2010; 78: 881-896
    CrossrefPubMedGoogle Scholar
  • 30 Khateeb S, Albalawi A, Alkhedaide A. Regulatory effect of diosgenin on lipogenic genes expression in high-fat diet-induced obesity in mice. Saudi J Biol Sci 2021; 28: 1026-1032
    CrossrefPubMedGoogle Scholar
  • 31 Khateeb S, Albalawi A, Alkhedaide A. Diosgenin Modulates Oxidative Stress and Inflammation in High-Fat Diet-Induced Obesity in Mice. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2022; 1589-1596
    PubMedGoogle Scholar
  • 32 Jagadeesan J, Nandakumar N, Rengarajan T, Balasubramanian MP. Diosgenin, a steroidal saponin, exhibits anticancer activity by attenuating lipid peroxidation via enhancing antioxidant defense system during NMU-induced breast carcinoma. J Environ Pathol Toxicol Oncol 2012; 31: 2
    CrossrefPubMedGoogle Scholar
  • 33 Kiasalari Z, Rahmani T, Mahmoudi N, Baluchnejadmojarad T, Roghani M. Diosgenin ameliorates development of neuropathic pain in diabetic rats: Involvement of oxidative stress and inflammation. Biomed Pharmacother 2017; 86: 654-661
    CrossrefPubMedGoogle Scholar
  • 34 Manivannan J, Arunagiri P, Sivasubramanian J, Balamurugan E. Diosgenin prevents hepatic oxidative stress, lipid peroxidation and molecular alterations in chronic renal failure rats. International Journal of Nutrition, Pharmacology, Neurological Diseases 2013; 3: 289
    CrossrefPubMedGoogle Scholar
  • 35 Li R, Liu Y, Shi J, Yu Y, Lu H, Yu L, Liu Y, Zhang F. Diosgenin regulates cholesterol metabolism in hypercholesterolemic rats by inhibiting NPC1L1 and enhancing ABCG5 and ABCG8. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids 2019; 1864: 1124-1133
    CrossrefPubMedGoogle Scholar
  • 36 Tsukayama I, Mega T, Hojo N, Toda K, Kawakami Y, Takahashi Y, Suzuki-Yamamoto T. Diosgenin suppresses COX-2 and mPGES-1 via GR and improves LPS-induced liver injury in mouse. Prostaglandins Other Lipid Mediat 2021; 156: 106580
    CrossrefPubMedGoogle Scholar
  • 37 Xie W-L, Jiang R, Shen X-L, Chen Z-Y, Deng X-M. Diosgenin attenuates hepatic stellate cell activation through transforming growth factor-β/Smad signaling pathway. Int J Clin Exp Med 2015; 8: 20323
    PubMedGoogle Scholar
  • 38 Aghemo A, Alekseeva OP, Angelico F, Bakulin IG, Bakulina NV, Bordin D, Bueverov AO, Drapkina OM, Gillessen A, Kagarmanova EM. Role of silymarin as antioxidant in clinical management of chronic liver diseases: A narrative review. Ann Med 2022; 54: 1548-1560
    CrossrefPubMedGoogle Scholar
  • 39 Dai C, Xiao X, Li D, Tun S, Wang Y, Velkov T, Tang S. Chloroquine ameliorates carbon tetrachloride-induced acute liver injury in mice via the concomitant inhibition of inflammation and induction of apoptosis. Cell Death Dis 2018; 9: 1164
    CrossrefPubMedGoogle Scholar
  • 40 Hao Y, Gao X. Diosgenin protects retinal pigment epithelial cells from inflammatory damage and oxidative stress induced by high glucose by activating AMPK/Nrf2/HO-1 pathway. Immun Inflamm Dis 2022; 10: e698
    CrossrefPubMedGoogle Scholar
  • 41 Khosravi Z, Sedaghat R, Baluchnejadmojarad T, Roghani M. Diosgenin ameliorates testicular damage in streptozotocin-diabetic rats through attenuation of apoptosis, oxidative stress, and inflammation. Int Immunopharmacol. 2019; 70: 37-46
    CrossrefPubMedGoogle Scholar